Holzer Holzer & Fistel, LLC is investigating potential violations of the federal securities laws by Hospira, Inc. (“Hospira” or the “Company”) (NYSE: HSP). The investigation focuses on whether a series of statements made between March 24, 2009 and October 17, 2011, inclusive, regarding Hospira’s business, its prospects and its operations were materially false and misleading at the time they were made. Specifically, the investigation seeks to determine whether Hospira understated quality control issues it was facing with its Project Fuel. The investigation further seeks to determine whether Hospira failed to disclose the extent of its inability to comply with problems identified in Food and Drug Administration Warning Letters relating to its infusion pumps, quality control deficiencies and manufacturing weaknesses.

If you purchased Hospira common stock between March 24, 2009 and October 17, 2011, inclusive, and have questions concerning your legal rights, you are encouraged to contact Holzer Holzer & Fistel, LLC and its attorneys Michael I. Fistel Jr., Esq. or Marshall P. Dees, Esq. via email at mfistel@holzerlaw.com, or mdees@holzerlaw.com, or via toll-free telephone at (888) 508-6832.

Holzer Holzer & Fistel, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer Holzer & Fistel, LLC has paid for the dissemination of this promotional communication, and Michael I. Fistel, Jr. is the attorney responsible for its content.

Copyright Business Wire 2010